These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1291 related items for PubMed ID: 16291984

  • 1. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G, Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.
    N Engl J Med; 2005 Nov 17; 353(20):2148-57. PubMed ID: 16291984
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R.
    Am Heart J; 2006 Apr 17; 151(4):851.e1-5. PubMed ID: 16569546
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A, Mathew V, Sahu A, Lunia B.
    Indian Heart J; 2003 Apr 17; 55(1):55-9. PubMed ID: 12760589
    [Abstract] [Full Text] [Related]

  • 4. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.
    Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893
    [Abstract] [Full Text] [Related]

  • 6. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
    Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA.
    N Engl J Med; 1998 May 14; 338(20):1397-404. PubMed ID: 9580646
    [Abstract] [Full Text] [Related]

  • 7. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
    Badesch DB, Hill NS, Burgess G, Rubin LJ, Barst RJ, Galiè N, Simonneau G, SUPER Study Group.
    J Rheumatol; 2007 Dec 14; 34(12):2417-22. PubMed ID: 17985403
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
    Barst RJ, Ivy DD, Gaitan G, Szatmari A, Rudzinski A, Garcia AE, Sastry BK, Pulido T, Layton GR, Serdarevic-Pehar M, Wessel DL.
    Circulation; 2012 Jan 17; 125(2):324-34. PubMed ID: 22128226
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
    Gomberg-Maitland M, McLaughlin V, Gulati M, Rich S.
    Am J Cardiol; 2005 Nov 01; 96(9):1334-6. PubMed ID: 16253609
    [Abstract] [Full Text] [Related]

  • 10. Sildenafil for primary and secondary pulmonary hypertension.
    Watanabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran QK, Satoh H, Terada H, Ohashi H, Hayashi H.
    Clin Pharmacol Ther; 2002 May 01; 71(5):398-402. PubMed ID: 12011826
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C, Escribano Subias P, Tello de Meneses R, Delgado Jiménez JF, Sadia Pérez D, Velázquez Martín MT, Gómez Sánchez MA, Sáenz de la Calzada C.
    Rev Esp Cardiol; 2004 Oct 01; 57(10):946-51. PubMed ID: 15469792
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.
    J Heart Lung Transplant; 2007 Nov 01; 26(11):1079-83. PubMed ID: 18022071
    [Abstract] [Full Text] [Related]

  • 13. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
    Madden BP, Allenby M, Loke TK, Sheth A.
    Vascul Pharmacol; 2006 May 01; 44(5):372-6. PubMed ID: 16574495
    [Abstract] [Full Text] [Related]

  • 14. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
    Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, Seeger W, Grimminger F.
    Ann Intern Med; 2004 Aug 03; 141(3):169-77. PubMed ID: 15289213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase type 5 and high altitude pulmonary hypertension.
    Aldashev AA, Kojonazarov BK, Amatov TA, Sooronbaev TM, Mirrakhimov MM, Morrell NW, Wharton J, Wilkins MR.
    Thorax; 2005 Aug 03; 60(8):683-7. PubMed ID: 16061711
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.
    Mukhopadhyay S, Sharma M, Ramakrishnan S, Yusuf J, Gupta MD, Bhamri N, Trehan V, Tyagi S.
    Circulation; 2006 Oct 24; 114(17):1807-10. PubMed ID: 17030688
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
    Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I.
    Circulation; 2005 Jun 21; 111(24):3274-80. PubMed ID: 15956137
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D, Chaumais MC, Savale L, Natali D, Price LC, Jaïs X, Humbert M, Simonneau G, Sitbon O.
    Adv Ther; 2009 Sep 21; 26(9):813-25. PubMed ID: 19768639
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Izbicki G, Rosengarten D, Picard E.
    N Engl J Med; 2006 Mar 09; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528809
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.